Radke Peter W, Schunkert Heribert
Eur Heart J. 2008 Jan;29(2):141-3. doi: 10.1093/eurheartj/ehm595.
This editorial refers to The impact of glucose-lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial by L.G. Mellbin et al., on page 166 and Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart by M. Alselmino et al., on page 177
本社论涉及L.G. Mellbin等人在第166页发表的《降糖治疗对2型糖尿病合并心肌梗死患者长期预后的影响:DIGAMI 2试验报告》,以及M. Alselmino等人在第177页发表的《冠心病患者的降糖治疗不仅对已确诊的糖尿病,而且对新发现的糖尿病在预后方面都很重要:糖尿病与心脏欧洲心脏调查的报告》